Short and Robust Anti-Infective Lipopeptides Engineered Based on the Minimal Antimicrobial Peptide KR12 of Human LL-37.
暂无分享,去创建一个
Guangshun Wang | Xiuqing Wang | Yingxia Zhang | A. Verma | Biswajit Mishra | T. Lushnikova | Radha M Golla | Vikas Kumar | Jayaram Lakshmaiah Narayana | Jingwei Xie | Radha M. Golla | Jingwei Xie
[1] Guangshun Wang,et al. Two distinct amphipathic peptide antibiotics with systemic efficacy , 2020, Proceedings of the National Academy of Sciences.
[2] Guangshun Wang,et al. Resistome of Staphylococcus aureus in Response to Human Cathelicidin LL-37 and Its Engineered Antimicrobial Peptides. , 2020, ACS infectious diseases.
[3] Steven B. Bradfute,et al. Engineered Human Cathelicidin Antimicrobial Peptides Inhibit Ebola Virus Infection , 2020, iScience.
[4] D. Davidson,et al. Antimicrobial host defence peptides: functions and clinical potential , 2020, Nature Reviews Drug Discovery.
[5] K. Rosengren,et al. Backbone Cyclization and Dimerization of LL-37-Derived Peptides Enhance Antimicrobial Activity and Proteolytic Stability , 2020, Frontiers in Microbiology.
[6] E. Sikorska,et al. Lipidated Analogs of the LL-37-Derived Peptide Fragment KR12—Structural Analysis, Surface-Active Properties and Antimicrobial Activity , 2020, International journal of molecular sciences.
[7] J. Drijfhout,et al. Potential factors contributing to the poor antimicrobial efficacy of SAAP-148 in a rat wound infection model , 2019, Annals of Clinical Microbiology and Antimicrobials.
[8] Guangshun Wang,et al. Modulation of antimicrobial potency of human cathelicidin peptides against the ESKAPE pathogens and in vivo efficacy in a murine catheter-associated biofilm model. , 2019, Biochimica et biophysica acta. Biomembranes.
[9] Guangshun Wang,et al. Low cationicity is important for systemic in vivo efficacy of database-derived peptides against drug-resistant Gram-positive pathogens , 2019, Proceedings of the National Academy of Sciences.
[10] Guangshun Wang,et al. Nanofiber Dressings Topically Delivering Molecularly Engineered Human Cathelicidin Peptides for the Treatment of Biofilms in Chronic Wounds. , 2019, Molecular pharmaceutics.
[11] Guangshun Wang,et al. Design of Antimicrobial Peptides: Progress Made with Human Cathelicidin LL-37. , 2019, Advances in experimental medicine and biology.
[12] Guangshun Wang,et al. Antimicrobial peptide LL-37 and its truncated forms, GI-20 and GF-17, exert spermicidal effects and microbicidal activity against Neisseria gonorrhoeae , 2018, Human reproduction.
[13] A. Løbner-Olesen,et al. LL‐37 fragments have antimicrobial activity against Staphylococcus epidermidis biofilms and wound healing potential in HaCaT cell line , 2018, Journal of peptide science : an official publication of the European Peptide Society.
[14] Guangshun Wang,et al. Amino Acid Composition Determines Peptide Activity Spectrum and Hot‐Spot‐Based Design of Merecidin , 2018, Advanced biosystems.
[15] Guangshun Wang,et al. Cathelicidin-Derived Antimicrobial Peptides Inhibit Zika Virus Through Direct Inactivation and Interferon Pathway , 2018, Front. Immunol..
[16] J. Drijfhout,et al. The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms , 2018, Science Translational Medicine.
[17] Guangshun Wang,et al. Host defense antimicrobial peptides as antibiotics: design and application strategies. , 2017, Current opinion in chemical biology.
[18] E. Y. Kim,et al. LL-37-derived membrane-active FK-13 analogs possessing cell selectivity, anti-biofilm activity and synergy with chloramphenicol and anti-inflammatory activity. , 2017, Biochimica et biophysica acta. Biomembranes.
[19] E. Medina,et al. IL-10 Plays Opposing Roles during Staphylococcus aureus Systemic and Localized Infections , 2017, The Journal of Immunology.
[20] K. Sayama,et al. TLN-58, an Additional hCAP18 Processing Form, Found in the Lesion Vesicle of Palmoplantar Pustulosis in the Skin. , 2017, The Journal of investigative dermatology.
[21] Guangshun Wang,et al. Anti-Staphylococcal Biofilm Effects of Human Cathelicidin Peptides. , 2016, ACS medicinal chemistry letters.
[22] Guangshun Wang,et al. Identifying the Critical Domain of LL-37 Involved in Mediating Neutrophil Activation in the Presence of Influenza Virus: Functional and Structural Analysis , 2015, PloS one.
[23] M. Plikus,et al. Dermal adipocytes protect against invasive Staphylococcus aureus skin infection , 2015, Science.
[24] Guangshun Wang,et al. High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments. , 2014, Biochimica et biophysica acta.
[25] Guangshun Wang,et al. Transformation of Human Cathelicidin LL-37 into Selective, Stable, and Potent Antimicrobial Compounds , 2014, ACS chemical biology.
[26] Guangshun Wang,et al. Human Antimicrobial Peptides and Proteins , 2014, Pharmaceuticals.
[27] T. Kielian,et al. A mouse model of Staphylococcus catheter-associated biofilm infection. , 2014, Methods in molecular biology.
[28] J. Bang,et al. Short KR‐12 analogs designed from human cathelicidin LL‐37 possessing both antimicrobial and antiendotoxic activities without mammalian cell toxicity , 2013, Journal of peptide science : an official publication of the European Peptide Society.
[29] Guangshun Wang,et al. Structural location determines functional roles of the basic amino acids of KR-12, the smallest antimicrobial peptide from human cathelicidin LL-37. , 2013, RSC advances.
[30] A. Hakansson,et al. Sensitization of Staphylococcus aureus to Methicillin and Other Antibiotics In Vitro and In Vivo in the Presence of HAMLET , 2013, PloS one.
[31] Liliane Schoofs,et al. A comprehensive summary of LL-37, the factotum human cathelicidin peptide. , 2012, Cellular immunology.
[32] J. Bang,et al. Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37 , 2012, Peptides.
[33] Guangshun Wang,et al. Database screening and in vivo efficacy of antimicrobial peptides against methicillin-resistant Staphylococcus aureus USA300. , 2012, International journal of antimicrobial agents.
[34] L. Rice. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. , 2008, The Journal of infectious diseases.
[35] Y. Carmeli,et al. Improved antimicrobial peptides based on acyl-lysine oligomers , 2007, Nature Biotechnology.
[36] Y. Shai,et al. Ultrashort antibacterial and antifungal lipopeptides , 2006, Proceedings of the National Academy of Sciences.
[37] Ayyalusamy Ramamoorthy,et al. LL-37, the only human member of the cathelicidin family of antimicrobial peptides. , 2006, Biochimica et biophysica acta.
[38] Guangshun Wang,et al. Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region. , 2006, Journal of the American Chemical Society.
[39] J. J. Grote,et al. Development of novel LL-37 derived antimicrobial peptides with LPS and LTA neutralizing and antimicrobial activities for therapeutic application , 2006, Peptides.
[40] R. Gallo,et al. Structure-Function Relationships among Human Cathelicidin Peptides: Dissociation of Antimicrobial Properties from Host Immunostimulatory Activities , 2005, The Journal of Immunology.
[41] J. Johansson,et al. The antimicrobial peptide LL-37 binds to the human plasma protein apolipoprotein A-I. , 2004, Rapid communications in mass spectrometry : RCM.
[42] R. Gallo,et al. Postsecretory Processing Generates Multiple Cathelicidins for Enhanced Topical Antimicrobial Defense1 , 2004, The Journal of Immunology.
[43] R. Hancock,et al. The Human Antimicrobial Peptide LL-37 Is a Multifunctional Modulator of Innate Immune Responses1 , 2002, The Journal of Immunology.
[44] Takaaki Ohtake,et al. Innate antimicrobial peptide protects the skin from invasive bacterial infection , 2001, Nature.
[45] J. Johansson,et al. Apolipoprotein A-I Binds and Inhibits the Human Antibacterial/Cytotoxic Peptide LL-37* , 1998, The Journal of Biological Chemistry.
[46] J. Odeberg,et al. FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.